Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bressac

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
British Journal of Cancer|July 10, 2008
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanomaF Lesueur, M de Lichy, M Barrois, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
British Journal of Cancer|July 10, 2008
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanomaF Lesueur, M de Lichy, M Barrois, et al.
Pageof 7